\-\ Texto\\:\\ \ \(0\)\
\-\ hiv\\ \\(\\-\\)\ \(0\)\
\-\ chemotherapy\\ and\\ \\ radiation\ \(0\)\
\-\ \\â\\€\\¢\\ extensive\\ abnormal\\ enhancement\\ of\\ the\\ sulci\\ and\\ subarachnoid\\ spaces\\ overlying\\ the\\ cerebral\\ hemispheres\\ and\\ cerebellum\ \(0\)\
\-\ \\â\\€\\¢\\ extensive\\ deep\\ white\\ matter\\ changes\ \(0\)\
\-\ \\â\\€\\¢\\ mild\\ hydrocephalus\ \(0\)\
\-\ secondary\\ cns\\ lymphoma\\,\\ subarachnoid\\ spread\\ \\(carcinomatous\\ meningitis\\)\ \(0\)\
\-\ \\â\\€\\¢\\ bacterial\\ meningitis\ \(0\)\
\-\ \\â\\€\\¢\\ subarachnoid\\ hemorrhage\ \(1\)\
\-\ \\â\\€\\¢\\ carcinomatous\\ meningitis\ \(0\)\
\-\ 64\\ year\\ old\\ man\\ presents\\ with\\ altered\\ mental\\ status\\ and\\ lethargy\\.\ \(1\)\
\-\ this\\ man\\ had\\ been\\ treated\\ previously\\,\\ for\\ an\\ abdominal\\ and\\ thoracic\\ diffuse\\ large\\ b\\ cell\\ lymphoma\\ \\(dlbcl\\)\\ \\,\\ over\\ the\\ past\\ 3\\ years\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ carcinomatous\\:\\ 0\\.152657961664693\ \(0\)\
\-\ meningitis\\:\\ 0\\.14778305964308722\ \(0\)\
\-\ subarachnoid\\:\\ 0\\.13840264432848104\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.10446762343972586\ \(0\)\
\-\ dlbcl\\:\\ 0\\.09795020471073887\ \(0\)\
\-\ extensive\\:\\ 0\\.07594123827663879\ \(0\)\
\-\ lethargy\\:\\ 0\\.05979479132757058\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0542710807642108\ \(0\)\
\-\ sulci\\:\\ 0\\.054263253236024135\ \(0\)\
\-\ altered\\:\\ 0\\.0538358501157153\ \(0\)\
\-\ hiv\\:\\ 0\\.05264423311178643\ \(0\)\
\-\ 64\\:\\ 0\\.05174039267340918\ \(0\)\
\-\ hemispheres\\:\\ 0\\.05058709496583537\ \(0\)\
\-\ cns\\:\\ 0\\.04858741297195757\ \(0\)\
\-\ bacterial\\:\\ 0\\.04858741297195757\ \(0\)\
\-\ cerebellum\\:\\ 0\\.047235224805540696\ \(0\)\
\-\ spaces\\:\\ 0\\.046781647088648966\ \(0\)\
\-\ spread\\:\\ 0\\.04592652440935865\ \(0\)\
\-\ man\\:\\ 0\\.04490959651311109\ \(0\)\
\-\ b\\:\\ 0\\.04475585201316058\ \(0\)\
\-\ mental\\:\\ 0\\.04430227429626886\ \(0\)\
\-\ overlying\\:\\ 0\\.042963983706537\ \(0\)\
\-\ hydrocephalus\\:\\ 0\\.04082060963848709\ \(0\)\
\-\ previously\\:\\ 0\\.03988635278059219\ \(0\)\
\-\ deep\\:\\ 0\\.0384325794366054\ \(0\)\
\-\ matter\\:\\ 0\\.03738311078223109\ \(0\)\
\-\ thoracic\\:\\ 0\\.036600638956713914\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.034032730946009615\ \(0\)\
\-\ status\\:\\ 0\\.03389252579090726\ \(0\)\
\-\ cerebral\\:\\ 0\\.03289385001960079\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.031602850935289285\ \(0\)\
\-\ white\\:\\ 0\\.03149004680791131\ \(0\)\
\-\ radiation\\:\\ 0\\.031158347217359293\ \(0\)\
\-\ past\\:\\ 0\\.030168883021627048\ \(0\)\
\-\ diffuse\\:\\ 0\\.028744526893059053\ \(0\)\
\-\ treated\\:\\ 0\\.028420564845376216\ \(0\)\
\-\ years\\:\\ 0\\.02788047930020536\ \(0\)\
\-\ changes\\:\\ 0\\.02721164418038956\ \(0\)\
\-\ abnormal\\:\\ 0\\.027078802670165682\ \(0\)\
\-\ secondary\\:\\ 0\\.02654477740565342\ \(0\)\
\-\ been\\:\\ 0\\.02583105432737768\ \(0\)\
\-\ cell\\:\\ 0\\.025647119017572072\ \(0\)\
\-\ enhancement\\:\\ 0\\.025449875179144845\ \(0\)\
\-\ mild\\:\\ 0\\.02500281615479041\ \(0\)\
\-\ over\\:\\ 0\\.024173806557110697\ \(0\)\
\-\ \\(\\:\\ 0\\.024078724208128684\ \(0\)\
\-\ \\)\\:\\ 0\\.02378458973711017\ \(0\)\
\-\ abdominal\\:\\ 0\\.023732435979134613\ \(0\)\
\-\ 3\\:\\ 0\\.022233061407850443\ \(0\)\
\-\ large\\:\\ 0\\.020761582575900887\ \(0\)\
\-\ had\\:\\ 0\\.02048722021378565\ \(0\)\
\-\ \\-\\:\\ 0\\.02035253843009293\ \(0\)\
\-\ presents\\:\\ 0\\.019396047727865844\ \(0\)\
\-\ an\\:\\ 0\\.013129609603163665\ \(0\)\
\-\ this\\:\\ 0\\.010679302370157033\ \(0\)\
\-\ year\\:\\ 0\\.010623391880810164\ \(0\)\
\-\ and\\:\\ 0\\.01000050031845658\ \(0\)\
\-\ old\\:\\ 0\\.009721495520691719\ \(0\)\
\-\ \\,\\:\\ 0\\.009023668850576245\ \(0\)\
\-\ for\\:\\ 0\\.008101201651585723\ \(0\)\
\-\ the\\:\\ 0\\.00460830949012086\ \(0\)\
\-\ with\\:\\ 0\\.001300046400998775\ \(0\)\
\-\ of\\:\\ 0\\.0012944866755332048\ \(0\)\
\-\ \\.\\:\\ 0\\.0007888785799410284\ \(0\)\
